Primary Dysmenorrhea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: To intervention, the experimental group will be asked to take 50 mg zinc sulphate orally twice a day for three days (Which can vary between 1 to 4 days) before the menstruation. Interv
Treatment - Drugs
Placebo
To intervention, the control group will be asked to take the placebo, which is as like as main medicine, orally twice a day for three days (Which can vary between 1 to 4 days) before the menstruation.
To intervention, the experimental group will be asked to take 50 mg zinc sulphate orally twice a day for three days (Which can vary between 1 to 4 days) before the menstruation.
Sponsors
Mother and Child Care Research Center, Vice Chancellor for Research and Technology
Eligibility
Sex/Gender
Female
Age
19 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Being volunteer to participate in the research; Having primary dysmenorrhea at least during three previous cycles which is approved by the researchers in the consultation; Having regular menstrual cycles between 21 days up to 35 days Having physical and mental health; Lack of using zinc as a dietary supplement during the last three months; Lack of sensitivity to zinc compounds Exclusion criteria: Changing Participant's mind for any reason and at any time ; Failure to attend counseling sessions; Failure to meet the guidelines defined in the study for any reason and at any time Exclusion criteria: Changing Participant's mind for any reason and at any time ; Failure to attend counseling sessions; Failure to meet the guidelines defined in the study for any reason and at any time
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of Dysmenorrhea. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire.;Intensity of Dysmenorrhea. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: VAS.;Nausea and vomiting. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Nausea Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of using conventional Medical treatments. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire.;Amount of using conventional Medical treatments. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire.;Duration of using conventional Non-medical treatments. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire.;Amount of using conventional Non-medical treatments. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire.;Failure to perform formal daily activities. Timepoint: Pre and Post interventional phase (two menstrual cycle). Method of measurement: Self-expressed Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahnaz Khatiban
Mother and Child Care Center, College of Nursing and Midwifery, Hamadan University of Medical Scienc
Outcome results
None listed